204 related articles for article (PubMed ID: 2143536)
1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
[TBL] [Abstract][Full Text] [Related]
2. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
3. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
Sybertz EJ; Chiu PJ; Vemulapalli S; Pitts B; Foster CJ; Watkins RW; Barnett A; Haslanger MF
J Pharmacol Exp Ther; 1989 Aug; 250(2):624-31. PubMed ID: 2547941
[TBL] [Abstract][Full Text] [Related]
4. Prolonged neutral endopeptidase inhibition in heart failure.
Helin K; Tikkanen I; Tikkanen T; Saijonmaa O; Sybertz EJ; Vemulapalli S; Sariola H; Fyhrquist F
Eur J Pharmacol; 1991 May; 198(1):23-30. PubMed ID: 1655477
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
6. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
7. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
Helin K
Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
[TBL] [Abstract][Full Text] [Related]
8. Attenuated diuretic and natriuretic effects of atrial natriuretic peptide in rats with heart failure.
Tikkanen T; Tikkanen I; Sariola H; Svartström-Fraser M; Fyhrquist F
Horm Metab Res; 1989 Apr; 21(4):185-8. PubMed ID: 2526789
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
10. [Significance of atrial natriuretic peptide in heart failure: experimental findings].
Drexler H; Hirth C; Stasch JP; Lang RE; Finckh M; Maio G; Just H
Z Kardiol; 1988; 77 Suppl 2():47-50. PubMed ID: 2970172
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
[TBL] [Abstract][Full Text] [Related]
12. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide is not elevated in rat plasma by heart failure or by neutral endopeptidase inhibition.
Helin K; Tikkanen I; Kiilavuori K; Näveri H; Fyhrquist F
Life Sci; 1994; 55(6):471-7. PubMed ID: 8035665
[TBL] [Abstract][Full Text] [Related]
14. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
15. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
16. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
Murohara Y; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
[TBL] [Abstract][Full Text] [Related]
17. Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats.
Feng QP; Carlsson S; Thorén P; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1129-35. PubMed ID: 1534840
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
[TBL] [Abstract][Full Text] [Related]
19. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]